Shares of NIOX Group Plc (LON:NIOX – Get Free Report) dropped 0.3% during mid-day trading on Thursday . The company traded as low as GBX 58.02 ($0.72) and last traded at GBX 59.80 ($0.74). Approximately 71,954 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 613,943 shares. The stock had previously closed at GBX 60 ($0.74).
NIOX Group Stock Up 0.3 %
The company has a fifty day moving average of GBX 61.78 and a 200 day moving average of GBX 64.10. The company has a quick ratio of 1.94, a current ratio of 6.32 and a debt-to-equity ratio of 1.10. The company has a market cap of £254.48 million, a P/E ratio of 3,000.00 and a beta of 0.92.
Insider Activity
In related news, insider Jonathan Emms purchased 31,604 shares of NIOX Group stock in a transaction on Wednesday, December 18th. The stock was acquired at an average price of GBX 63 ($0.78) per share, for a total transaction of £19,910.52 ($24,675.33). Insiders own 46.72% of the company’s stock.
NIOX Group Company Profile
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Featured Articles
- Five stocks we like better than NIOX Group
- The How and Why of Investing in Gold Stocks
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- What is a Stock Market Index and How Do You Use Them?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Trading Stocks: RSI and Why it’s Useful
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.